Zobrazeno 1 - 10 of 346 pro vyhledávání: '"Gitlin, N"'
1
Perhexiline maleate in the management of patients with angina pectoris
Autor: Gitlin, N
Publikováno v: South African Medical Journal; Vol 48, No 5 (1974)
South African Medical Journal; Vol 47, No 5 (1973)
In a single-blind study lasting 6 months an entirely new anti-anginal preparation, perhexiline maleate (Pexid), was prescribed in a dose of 200 mg b.d. to 21 patients suffering from angina pectoris. There was a statistically significant reduction in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c37c81ac8d4fe221d8cf1a836556fecf
https://www.ajol.info/index.php/samj/article/view/188964
Zobrazit plný text záznamu
3
The incidence of Australia antigen/antibody in acute and chronic liver disease
Autor: Meyers, O.L., Gowdeswell, I.R.G., Gitlin, N., Keraan, M.
Publikováno v: South African Medical Journal; Vol 45, No 10 (1971); 1164-1166
South African Medical Journal; Vol 45, No 9 (1971)
The Australia (AujSH) antigen was sought in patients with -acute viral hepatitis, chronic hepatitis, cirrhosis and hepatoma of the liver. Thirty per cent of patients with :infectious hepatitis and 50% of patients with serum hepatitis had positive tes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9ae7b3aacfc426f2dc48ba9cdae80dcd
https://www.ajol.info/index.php/samj/article/view/171086
Zobrazit plný text záznamu
4
The Antistreptolysin Titre (ASO Titre) as a diagnostic index in hepatitis
Autor: Gitlin, N, Dowdeswell, I.R., Meyers, O.L., Forder, A.A.
Publikováno v: South African Medical Journal; Vol 45, No 10 (1971); 1162-1163
A series of patients suffering from hepatitis and jaundice were studied in order to ascertain whether the ASO titre would assist in early diagnosis of these diseases, and whether it would help in the differentiation of the various types of hepatitis.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::720d4026df40daa6a710fd8b9469dce4
https://www.ajol.info/index.php/samj/article/view/171085
Zobrazit plný text záznamu
5
The antistreptolysin titre diagnostic index (Aso titre) hepatitis
Autor: Gitlin, N., Dowdeswell, I.R., Meyers, O.L.
Publikováno v: South African Medical Journal; Vol 45, No 9 (1971)
series of patients suffering from hepatitis and jaundice were studied in order to ascertain whether the ASO titre would assist in early diagnosis of these diseases, and whether it would help in the differentiation of the various types of hepatitis.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::9669957af373750f54b2f7f774acc1de
https://www.ajol.info/index.php/samj/article/view/170454
Zobrazit plný text záznamu
6
Salicylate hepatitis
Autor: Gitlin, N, Dietrich, B, Spektor, F
Publikováno v: South African Medical Journal; Vol 47, No 9 (1973)
A case report of salicylate hepatitis is discussed and a predictable direct drug dosage mechanism is suggested as the pathogenesis. However, a striking eosinophilia and eosinophil infiltration of the portal tract also raises the possibility of a hype
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::6a82bc2a1c15ce3e5e97d8d1ce407947
https://www.ajol.info/index.php/samj/article/view/169697
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Telaprevir for previously untreated chronic hepatitis C virus infection
Autor: Jacobson I. M., McHutchison J. G., Dusheiko G., Di Bisceglie A. M., Reddy K. R., Bzowej N. H., Marcellin P., Muir A. J., Ferenci P., Flisiak R., George J., Rizzetto M., Shouval D., Sola R., Terg R. A., Yoshida E. M., Adda N., Bengtsson L., Sankoh A. J., Kieffer T. L., George S., Kauffman R. S., Zeuzem S., ADVANCE Study Team: Gadano A., Terg R., Bell S., Cheng W., Crawford D., Dore G., MacDonald G., Roberts S., Gschwantler M., Laferl H., Maieron A., Heathcote J., Kaita K., Myers R., Sherman M., Yoshida E., Barange K., Couzigou P., Pawlotsky J. M., Pol S., Serfaty L., Trépo C., Zarski J. P., Berg T., Buggisch P., Diepolder H., Goeser T., Mauss S., Rasenack J., Schmidt W., Wedemeyer H., Baruch Y., Ben Ari Z., Maor Y., Safadi R., Zuckerman E., Colombo M., Baka Cwierz B., Gladysz A., Janczewska Kazek E., Jablkowski M., Krycka W., Diago M., Esteban Mur R., Sanchez Tapias J., Brown A., Fox R., Afdhal N., Arora S., Bennett M., Bernstein D., Bloomer J., Bochan M., Bonkovsky H., Brady C., Brown R., Bzowej N., Cochran J., Chasen R., Davis G., De Jesus E., Di Bisceglie A., Dienstag J., Dieterich D., Etzkorn K., Everson G., Fried M., Freilich B., Ghalib R., Gitlin N., Godofsky E., Gordon S., Hassanein T., Jacobson I., Javadi F., Jonas M., Kilby A., Kwo P., Lawitz E., Lebovics E., Lee W., Luketic V., Maillard M., Monto A., Morgan T., Min A., Murphy M., Nelson D., Northup P., Nyberg L., Pockros P., Poordad F., Poulos J., Reddy R., Rodriguez Torres M., Satyanarayana R., Schiff E., Schwartz H., Shaikh O., Sheikh M., Sherman K., Smith J., Strohecker J., Sulkowski M., Szabo G., Te H., Terrault N., Tsai N., Vargas H., Vierling J., Wruble L., Younossi Z., Zein N., ANDREONE, PIETRO
A B S T R AC T Background In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with peginterferon–ribavirin, as compared with peginterferon–ribavirin alone, has shown improved efficacy, with poten
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052a883adee96e1a0f587feb78d8287d
http://hdl.handle.net/11585/129215
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje